Evaluation of Splinting in Tetraplegia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04523636 |
|
Recruitment Status :
Completed
First Posted : August 21, 2020
Last Update Posted : August 21, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Spinal Cord Injury Cervical Splints | Device: Splinting | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 36 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Each extremity was randomized to receive a custom or pre-fabricated resting hand splint. |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Evaluation of Splinting in Tetraplegia |
| Actual Study Start Date : | January 4, 2018 |
| Actual Primary Completion Date : | December 20, 2018 |
| Actual Study Completion Date : | December 20, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Custom Splint
Custom Splint- Thermoplastic device fabricated by occupational therapist
|
Device: Splinting
Pre-fabricated or custom resting hand splints |
|
Active Comparator: Prefabricated Splint
Prefabricated Splint- Commercially available from Restorative Care of America, Inc (RCAI)
|
Device: Splinting
Pre-fabricated or custom resting hand splints |
- Change in scores on The Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP). [ Time Frame: This assessment is completed within 5 days of initating the splinting intervention and within 3 days of discharge. Length of time between data collection was limited to 12 weeks. ]
This test is a hand function assessment for spinal cord injury consisting of four domains- upper extremity strength, sensation, qualitative prehension, and quantitative prehension. Total scores for each upper extremity are calculated 0-116. Assessment of the Hand in Tetraplegia Using the Graded Redefined Assessment of Strength Sensibility and Prehension (GRASSP): Impairment versus Function.
Kalsi-Ryan S, Curt A, Fehlings, MG and Verrier MC. Top Spinal Cord Inj Rehabil (2009); 14(4):34-46. - C
- Splint Perception Survey [ Time Frame: This assessment was completed within 3 days of discharge and no more than 12 weeks after the intervention was initiated. ]This survey gathered participant perceptions via a 5 point Likert scale on the participant's perceptions of the splint's comfort and impact on function and hand position. Additionally, participants were asked to provide their perceptions on challenges to using the splint and advice to future therapists and patients considering splinting.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Spinal Cord Injury
- Inpatient Rehabilitation
- Limited hand function
Exclusion Criteria:
- Under 18
- Full hand function
- Orthopedic injury to hand
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04523636
| United States, Maryland | |
| University of MD Rehabilitation & Orthopaedic Institute | |
| Baltimore, Maryland, United States, 21207 | |
| United States, Pennsylvania | |
| Thomas Jefferson University | |
| Philadelphia, Pennsylvania, United States, 19107 | |
| Principal Investigator: | Peter Gorman, MD | University of Maryland, Baltimore | |
| Principal Investigator: | Paula Geigle, PhD | University of Maryland, Baltimore | |
| Study Director: | Sara Frye, MS | Thomas Jefferson University |
| Responsible Party: | Thomas Jefferson University |
| ClinicalTrials.gov Identifier: | NCT04523636 |
| Other Study ID Numbers: |
HP-00075158 |
| First Posted: | August 21, 2020 Key Record Dates |
| Last Update Posted: | August 21, 2020 |
| Last Verified: | August 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Spinal Cord Injuries Quadriplegia Spinal Cord Diseases Central Nervous System Diseases Nervous System Diseases |
Trauma, Nervous System Wounds and Injuries Paralysis Neurologic Manifestations |

